FCGR2B and neoplasm: Additionally, these antibodies can boost the immune system’s ability to fight tumors by blocking inhibitory signals from receptors like Fc gamma receptor IIB (FcγRIIB), enhancing their effectiveness in tumor therapy [44,45,46].